Evidence map›Paper›PMID 35145229›Full record

ArticleMolecular psychiatry2022

Molecular origin of somatostatin-positive neuron vulnerability.

Toshifumi Tomoda, Akiko Sumitomo, Dwight Newton, Etienne Sibille

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. GABATrends in pharmacological sciences · 2023
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Toshifumi TomodaCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, M5T 1R8, Canada. Toshifumi.Tomoda@camh.ca.ORCID http://orcid.org/0000-0003-3587-0914
Akiko SumitomoCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, M5T 1R8, Canada.ORCID http://orcid.org/0000-0003-3051-0485
Dwight NewtonCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, M5T 1R8, Canada.
Etienne SibilleCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, M5T 1R8, Canada. Etienne.Sibille@camh.ca.ORCID http://orcid.org/0000-0001-5832-6570
Centre for Addiction and Mental Health · CA

Funding

Molecular Aging of the Human Brain: Genetic Modulation and Functional OutcomesR01MH093723 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SIBILLE, ETIENNE L · 2011 to 2015
$2.6M
CIHR PJT-153175NIMH NIH HHS R01 MH093723
6 · The paper itself

Abstract

Reduced somatostatin (SST) and dysfunction of SST-positive (SST

Indexed as

ProteomicsSomatostatinEndoplasmic Reticulum StressNeuronsPrefrontal CortexUnfolded Protein ResponseSomatostatin

Identifiers

PMID35145229
PMCPMC9133093
OpenAlexW4226085166

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.